FIELD: medicine.
SUBSTANCE: invention represents immunogenic hybrid polypeptide for prevention and treatment of obesity. Also described is vaccine for prevention or treatment of obesity, containing immunogenic hybrid polypeptide. In addition, describes are polynucleotide, coding immunogenic hybrid polypeptide, recombinant expression vector, carrying said polynucleotide, host cell, transformed by recombinant expression vector, and method of obtaining immunogenic hybrid polypeptide by cultivation of host cell, transformed by recombinant expression vector.
EFFECT: invention can be efficiently used as means for prevention or treatment of obesity.
18 cl, 25 dwg, 15 ex
